are equal contributors.
Introduction
Natural killer (NK) and cytotoxic CD8 þ T lymphocytes (CTL) kill virus-infected and tumor cells through the targeted delivery of cytotoxic granules. These cells can induce target cell death though two major mechanisms. One involves the rapid release of lytic granules containing cytotoxic molecules including perforin and granzymes 312 into a synaptic cleft formed between the effector and target cell upon triggering of the TCR or NK cell activating receptors. Upon perforin-facilitated entry into the target cell, granzyme protease activity cleaves critical cellular substrates leading to rapid DNA degradation and cell death. The second mechanism involves interactions between the TNFfamily cytokine Fas ligand (FasL, CD178) on effector cells with its cognate receptor Fas (CD95) on the cell surface of target cells. The binding of membrane-bound FasL with Fas induces cell death during target cell killing as well as autocrine and paracrine T cell death [1] . Although the perforin/granzyme system mediates efficient target cell killing, both CTL and NK cells appear to use FasL to some extent to kill target cells. In CTL, deficiencies in either the perforin-mediated or Fas-FasL pathway impairs, but does not completely abolish the killing ability of CTLs, whereas deficiencies of both systems abolish CTL activity [2, 3] . In NK cells, cytolytic activity can also be significantly inhibited in the presence of antibodies against Fas, suggesting a non-redundant role for FasL-Fas interactions in NK cell-mediated cytotoxicity as well [4, 5] . Thus, the FasL-Fas pathway appears to be an alternate lytic system to the perforin/granzyme pathway in both CTL and NK cells. Genetic studies have revealed that Fas-FasL interactions are important in maintaining lymphocyte homeostasis and immunological self-tolerance, as seen in the lymphoaccumulation and autoantibody formation that ensues from deficiency in either Fas or FasL in lpr and gld mice [6, 7] . In humans, dominant negative mutations in Fas or FasL cause most cases of the Autoimmune Lymphoproliferative Syndrome (ALPS) [8, 9] . FasL-Fas interactions also play a role in killing virally infected cells and maintaining homeostasis of the anti-viral CTL pool during chronic infection [10] [11] [12] . These studies highlight the importance of understanding the mechanism by which FasL kills target cells.
FasL is synthesized as a type II transmembrane protein and can be secreted in soluble form after cleavage of the extracellular Fas-binding domain by the metalloprotease ADAM10 [13] . However, soluble FasL does not exert cytotoxicity and may in some cases inhibit apoptosis induced by membrane-bound FasL [14] . Membrane-bound surface FasL increases significantly upon T cell activation [15, 16] , and FasL at the plasma membrane may be capable of exerting lytic functions that would not require conjugate formation and directional granule release. Additionally, FasL has been detected on the membranes of secreted microvesicles, which are thought to derive from the inner vesicles of multivesicular bodies (MVB). Vesicular FasL may also be cytotoxic [17] [18] [19] [20] , but would require directed secretion into the immunological synapse for efficient function. Which of these forms of membrane FasL exerts cytotoxicity, and whether FasL traffics to the immunological synapse upon TCR and NK cell receptor triggering, is not known.
To better understand the mechanisms by which NK cells use FasL to kill target cells, we studied the intracellular localization of FasL in human NK cells virally transduced with FasL-fluorescent fusion proteins. We found that FasL is enriched on the membranes of intraluminal vesicles (ILVs) within CD63 and LAMP1-expressing secretory lysosomes, but is not found in the dense cores of secretory lysosomes, where perforin is present. FasL-containing secretory lysosomes accumulated at the immune synapse during NK-cell recognition of MHC-deficient target cells, with a secondary pool of FasL vesicles accumulating at the pole opposite to the immune synapse. These studies identify vesicular FasL as the form of FasL that is delivered to the immune synapse, mediating its cytotoxic potential.
Results
FasL localizes to a secretory lysosome compartment distinct from perforin in human NK cells
Previous studies in transiently transfected RBL cells and native FasL in fixed T and NK cells have shown that FasL primarily localizes in secretory lysosomes with a minority of FasL on the cell surface [21] . To examine FasL trafficking in living human NK cells, we generated clones of the human NK cell line YT that were retrovirally transduced to stably express a chimeric FasL protein with GFP fused to its intracellular amino terminus. To prevent spontaneous cytotoxic activity of FasL, the Fas-binding sequence of the extracellular domain of FasL (amino acid residue 218) was altered with a point mutation derived from gld mice, rendering FasL non-functional [22] [23] [24] . YT clones expressing FasL-GFP at equivalent levels were selected for study.
We first examined FasL localization in YT cell clones expressing FasL-GFP using confocal microscopy. Immunostained FasL and GFP showed complete colocalization, validating GFP as a marker for FasL (Fig. S1 ). Using antibodies labeling CD63, LAMP1, and perforin-positive compartments in NK cells, we studied the subcellular localization of FasL relative to components of the secretory lysosome. LAMP1 is a protein found on the limiting membrane of lysosomes, while CD63 is a protein found both on the limiting membrane and on the internal membranes of MVBs. In contrast, perforin and granzymes are often found in the dense core of secretory lysosomes [27] [28] [29] . We observed the greatest overlap between FasL and CD63þ compartments, with reduced colocalization with LAMP1 or perforin (Fig. 1) . Quantitative image analysis of colocalization in multiple cells confirmed this hierarchy, with greater colocalization of FasL with CD63 than with LAMP1 or perforin (Fig. 2) .
In addition we analyzed cells using a ''line-tool'' method to visualize the degree of co-localization between FasL and secretory compartments. This method quantitates the peak overlaps that occur between FasL and immunostained granules along a line selected to go through multiple granules in a single optical slice of the cell (Fig. S2) . Concordant with the colocalization analysis shown in Figure 2 , there was more frequent overlap in the peaks between FasL and CD63 than with perforin or LAMP1, although FasL was frequently observed in close proximity perforin, suggesting that they may in distinct compartments within the secretory lysosome. Taken together, these data show that in lymphocytes before contact with a target cell, FasL is enriched in CD63 þ vesicles and adjacent, but not colocalized with perforin within granules.
To investigate the localization of FasL in secretory vesicles in relation to perforin and granzyme B in more detail, we used immunogold labeling with an antibody against GFP to localize the FasL-GFP fusion protein via electron microscopy (EM). In YT cells stably expressing FasL-GFP, the GFP signal was detected predominantly on the ILVs within the secretory lysosomes, but was excluded from the electron dense cores which contain perforin and granzymes (Fig. 3A,B) . The number of gold particles per intraluminal vesicle (ILV) carrying FasL, ranged from 1 to 12 gold particles per ILV (mean ¼ 3, n ¼ 66) (Fig. 3B ). In addition, we detected minor gold labeling FasL-GFP in the Golgi ( Fig. 3C ). These data show that FasL is sorted to the ILVs of secretory lysosomes, positioning FasL to be present on the surface of a secreted vesicle in membrane-bound form, whereas FasL was not present in the electron-dense cytolytic granules
FasL relocalizes toward the immune synapse upon target cell recognition
To examine the trafficking behavior of FasL during interactions between NK and target cells, we imaged FasL-GFP in YT cells that had formed conjugates with 721.221 cells, a human B cell line lacking MHC class I expression. The lack of MHC class I relieves signaling through inhibitory receptors on NK cells, enabling conjugate formation, NK cell activation and target cell killing. We identified YT cells that had formed immune synapses with target cells as those in which perforin re-localized to the interface with the target cell. Confocal images of YT cells in which endogenous perforin had re-localized to the site of contact with 721.221 B cells revealed three distinct patterns of FasL-GFP localization (Fig. 4C) . In 52% of conjugates analyzed (n ¼ 42), intracellular FasL-containing vesicles polarized toward the immunological synapse and colocalized with perforin, with some FasL remaining at the distal pole of the cell (Fig. 4A) . In other conjugates (26%), almost all FasL was proximal to the immunological synapse (Fig. 4B) . FasL was exclusively localized to the distal pole of the cell only in 5% of conjugates examined. These results suggest that FasL is delivered to the immunological synapse after target cell recognition, but less efficiently than perforin, with a significant percentage of cells retaining FasL-containing vesicles at the opposite pole of the cell, distal from the immune synapse.
To confirm FasL localization to the IS in with other markers of the immune synapse in living cells, we imaged NK-cells transduced with FasL-GFP forming conjugates with 721.221 B cells using live cell confocal video microscopy. FasL could be seen to localize to the immune synapse in the central area of the IS surrounded by F-actin labeled by transfected LifeAct-EGFP (Fig. 5A) . The accompanying video (supplemental video 1) shows that FasL relocalizing away from the IS with similar kinetics to disassembly of F-actin at the target cell interface. Imaging of FasL with CD63-mCherry revealed colocalization of FasL and CD63 in the central portion of the NK-B immune synapse (Fig. S3 , supplemental video 2).
We asked whether FasL is released in vesicles upon degranulation by treating YT cells expressing FasL-GFP with PMA and ionomycin before fixation and labeling. Electron micrographs showed that small vesicles released upon degranulation were labeled with FasL-GFP, demonstrating that FasL is released in a membrane bound form upon secretion (Fig. 5C ).
Discussion
The transport and release of lytic proteins at the immunological synapse during target cell killing depends on the successful sorting of these proteins to secretory compartments. Human NK cells store lytic proteins such as perforin and granzymes in secretory lysosomes until signaled for degranulation [25] . Our results identify CD63 þ intraluminal vesicles (ILVs) within MVB as the primary subcellular compartment where FasL is localized. These results extend our earlier findings that FasL partially colocalized with perforin, cathepsin D, and granzyme A in NK cells [2] . We now show that FasL is primarily localized to [21] . The localization of FasL to intraluminal vesicles of cytolytic granules is important as this will direct FasL to be released in its more potent, membrane-bound form. Our results support earlier findings that FasL is found on exosomes [30] , as ILVs will give rise to exosomes when released. In T cells, TCR activation induces colocalization of ADAM10 and FasL and cleavage of FasL into a soluble form [31] , but it is not clear whether this occurs in NK cells. Although a significant portion of FasL-containing vesicles traffic to the immune synapse (IS) during conjugate formation with target cells, in a majority of cells, a portion of FasL localizes to the distal pole of the NK cell away from the immune synapse. FasL at the immune synapse is likely involved in the target cell killing, confirming functional studies showing that FasL and perforin/granzyme mediated target cell killing are independent cytotoxic effectors in CD8þ cytotoxic T cells and NK cells [5, 32] . The FasL at the distal pole of the cell may be in excess of the trafficking machinery needed to deliver FasL to the immune synapse, or may serve other functions. In T cells, the distal pole of the cell sequesters molecules such as CD43 away from the immune synapse and regulates T cell activation [33] . The function of the distal pole complex in NK cells is less well understood, but FasL localized to the distal pole would be well-positioned to induce cell death in bystander cells. In CD4 þ T cells, FasL induced by restimulation through the TCR can kill other T cells not presenting antigen to the effector cells in an autocrine manner through FasL secreted in microvesicles [34] . Since FasL-GFP is expressed at supra-physiological levels in these cell lines, this finding will need to be confirmed with endogenous FasL as well, although the localization of FasL to the immune synapse in NK cells is similar to what has been observed with native FasL in CD8 þ T cells [2] . As FasL trafficking is crucial for its function, these data provide additional information that may be useful for designing strategies to modulate the effects of FasL in relevant disease states.
Materials and Methods

Cell lines and culture
The human natural killer-like (NK) cell line YT was cultured in RPMI-1640 medium supplemented with 10% FCS, 100 U mL À1 rhIL-2 (Proleukin), 2 mM L-glutamine, 50 mM b-mercaptoethanol, (100 U mL
À1
) penicillin/ (100 mg mL À1 ) streptomycin, and 1% sodium pyruvate (Gibco, Thermofisher Scientific, Waltham, MA, USA). The Epstein-Barr Virus (EBV) transformed human B cell line, 721.221 was maintained in RPMI-1640, supplemented with 10% FCS and (100 U mL Transduced YT cell clones were isolated by limiting dilution and selected based on GFP-expression using flow cytometry.
Confocal immunofluorescence microscopy
YT cells were resuspended at 10 6 cells mL À1 in serum-free RPMI-1640 and adhered to glass slides for 30 min at 378C, washed with PBS, containing 0.1% bovine serum albumin (BSA) (Sigma-Aldrich), 0.02% sodium azide and fixed with ice-cold methanol for 5 min and washed in PBS before incubating for 1 h at room temperature in blocking buffer (PBS, 1% BSA). Samples were incubated with primary antibodies in PBS, 0.2% BSA for 1 h at room temperature, or overnight at 48C and washed extensively in PBS, 0.2% BSA before adding secondary antibodies for 40 min at room temperature. Nuclei were stained with Hoechst 33342 (1:20,000) (Invitrogen, Thermofisher Scientific, Waltham, MA, USA) in PBS for 1-2 min before mounting with number 1.5 coverglass and mounting medium (Mowiol). Fixed images were examined at room temperature using either Zeiss LSM510 confocal microscope (Carl Zeiss, Inc., Oberkochen, Germany), or with laser-scanning spinning-disk confocal system (Andor Revolution) with lasers exciting at 405, 488, 543, and 633 nm using the 63x or 100x (Plan-Apochromat, NA 1.40) oil immersion objective. Images were acquired using Image Pro (Zeiss, Inc.) or IQ software (Andor, Belfast, Northern Ireland). 
Colocalization analysis
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